PUBLIC LAB STATE · APPROVED 25 SEP 2026
This page records public-safe changes in the research program. It is generated only from an approved summary contract; strategy mechanics and portfolio composition never enter the website pipeline.
A living record of research lanes that can be acknowledged without disclosing MSRLab trade secrets.
A live, publicly observable MSRLab research portfolio. MSRLab has also purchased Darwinex Zero's maximum 600k Booster tier; this expands the opportunity set but is not a performance guarantee.
Open safe record ↗MSR-003 · Live test · public MQL5 recordliveA broker-specific live research lane now linked to a public MQL5 Signal record. Its components, settings, allocations, and operating mechanics remain confidential.
Open safe record ↗MSR-004 · Prospective lifecycle observationvalidationThe restart-safe forward engine completed its first field observation snapshot without duplicate-order or lifecycle-integrity failures. The sample is still too short for an economic conclusion, so the work remains shadow/demo research.
Open safe record ↗MSR-005 · Verified candidate · prospective evidence pendingvalidationA compact native candidate has passed its frozen historical challenge-path gates and operational packaging checks. Prospective/demo evidence and human approval are still required before any paid challenge or capital action.
Open safe record ↗MSR-007 · Platform validation and edge researchvalidationThe native platform continues to turn ideas into reproducible campaigns and portfolio decisions. A large generalized session-handoff study was rejected across chronology while its verified research infrastructure was retained for better hypotheses.
Open safe record ↗MSR-008 · New intake under frozen screeningvalidationExisting broker books remain under governed observation while a new range-oriented configuration intake proceeds through provenance, compatibility, frozen screening, and portfolio-usefulness gates. No new survivor or profitability claim is being made.
Open safe record ↗MSR-009 · Confidential capabilityactiveA controlled capability for installation, reproducibility, risk, portability, lifecycle, and regression testing. Collaborators, private artifacts, and findings are not disclosed.
Open safe record ↗MSR-010 · Qualified alternative · controlled transition boundaryvalidationReconstruction work now includes a newly curated alternative that passed frozen native qualification and local capacity preflight. Composition, economics, risk choices, and any transition decision remain confidential.
Open safe record ↗MSR-011 · UBS discovery campaign · validation pendingvalidationThe native transfer search closed without a deployable candidate, but a separate UBS community-set mining lane remains active. Early development results are encouraging enough to justify continued screening; chronology, realistic costs, real-tick confirmation, and final supplied-set disposition remain outstanding.
Open safe record ↗MSR-012 · Paid-product evidence and portfolio fitactiveA large commercial-product registry and evidence funnel are active. One incumbent remains deployed, but no newly researched product is currently purchase-ready or authorized for portfolio admission.
Open safe record ↗These are finished public software products. Their existence does not turn the surrounding research into a performance claim.
MSRLab's first public software product is now published on MQL5: a self-contained MT5 workstation for context, planning, risk framing, alerts, and journaling. It does not provide trade signals or disclose private portfolio intelligence.
Open product record ↗MSR-014 · Published on MQL5 · v2.105completedThe Strategy Engine is now published on MQL5 as a tool for building, testing, and combining user-owned profiles across breakout, trend, mean-reversion, volatility, and price-action approaches. Included examples demonstrate the workflow; they are not performance promises.
Open product record ↗Dated releases describe progress and governance—not proprietary mechanisms.
The Strategy Engine is now available as a self-contained MetaTrader 5 Expert Advisor for building, testing, and combining user-owned strategy profiles. Its included examples demonstrate the workflow; they are historical demonstrations, not signals or performance promises.
The native Weltrade transfer search remains a negative result, while the separate UBS community-set discovery lane is still active with encouraging preliminary development results. Full chronology, realistic-cost, real-tick, provenance, and portfolio gates remain outstanding before any promotion.
A dedicated $1,000 Deriv live research account is now running the historical Family Balanced UBS portfolio: 15 independently researched set files across 11 synthetic indices spanning the Boom, Crash, DEX, Jump, Step, and Volatility families. A public MQL5 Signal provides externally observable forward evidence. Rules, parameters, exact instrument mappings, allocations, and controls remain private.
MSRLab's first public software release is now available as a self-contained MetaTrader 5 decision-support workstation for scanning context, inspecting structure, planning risk, and journaling. It does not provide trade signals or expose private portfolio intelligence.
The Darwinex and Deriv portfolio pages now link to their public MQL5 Signal records. These links make outcomes observable without revealing strategy mechanics, configuration, portfolio membership, or risk controls.
MSRLab has purchased the maximum 600k Booster tier for its Darwinex Zero program. The purchase expands potential allocation capacity; it does not guarantee an allocation, return, or future performance.
Broad synthetic-market transfer work closed without a deployable portfolio, a small diagnostic shadow set remains under observation, commercial EA evaluation continues, and a new provenance-controlled range-oriented intake is in frozen development screening.
The Diversified Strategy Engine completed another large negative research campaign, the Context Matrix workstation entered product validation, and the prop-funding engine produced a verified candidate package that still requires prospective evidence and human approval.
Every executable candidate in the frozen free-source corpus received a final disposition. No new deployable edge survived the complete chain; the findings remain valuable negative evidence and will not be rescued through after-the-fact tuning.
A five-phase investigation spanning broad discovery, public source review, commercial-product intelligence, and attributable public-trader research closed with no new deployable edge. Its negative evidence and research infrastructure are retained.
PBZ now has a demo-only, restart-safe forward-research package. A separately governed prop-funding candidate is being observed in an FTMO 2-Step demo environment; neither lane has live-capital authority.
A 20-configuration licensed-strategy Deriv book is in demo testing, while the native diversified research platform retains a 12-profile validation book. Membership, mappings, settings, and risk budgets remain confidential.
MSRLab reconstructed a 71-component candidate universe across three broker-realistic periods and closely matched the deployed 58-component book. Compact alternatives remain shadow research; the live control was not replaced or resized.
MSRLab screened 76 exposed public records. No reproducible candidate passed the combined evidence, cost, robustness, and portfolio-usefulness gates; the program is paused pending materially new evidence.
MSRLab now publishes through an allow-listed summary contract. Raw research artifacts, strategy mechanics, deployed composition, and decision thresholds remain private.
Quant Mechanica and MQL5 research are documented as hypothesis sources. Independent results will be published only at a non-reconstructive evidence level.
Darwinex Zero provides an external verification record. A separate small-capital broker lane remains experimental and awaits public verification.